Search Results - "Dekker, FW"

Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease by Klatte, Derk C.F, Gasparini, Alessandro, Xu, Hong, de Deco, Pietro, Trevisan, Marco, Johansson, Anna L.V, Wettermark, Björn, Ärnlöv, Johan, Janmaat, Cynthia J, Lindholm, Bengt, Dekker, Friedo W, Coresh, Josef, Grams, Morgan E, Carrero, Juan J

“…Abstract Background & Aims Proton pump inhibitors (PPI) have been associated with acute kidney injury (AKI) and recent studies suggest that they may be…”
Get full text

Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy by Sijpkens, Yvo. W., Joosten, Simone A., Wong, Man-Chi, Dekker, Friedo W., Benediktsson, Hallgrimur, Bajema, Ingeborg M., Bruijn, Jan A., Paul, Leendert C.

“…Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Chronic transplant glomerulopathy is an uncommon cause of chronic…”
Get full text

Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study by Fu, Edouard L, Evans, Marie, Clase, Catherine M, Tomlinson, Laurie A, van Diepen, Merel, Dekker, Friedo W, Carrero, Juan J

“…It is unknown whether stopping renin-angiotensin system (RAS) inhibitor therapy in patients with advanced CKD affects outcomes. We studied patients referred to…”
Get full text

An introduction to inverse probability of treatment weighting in observational research by Chesnaye, Nicholas C, Stel, Vianda S, Tripepi, Giovanni, Dekker, Friedo W, Fu, Edouard L, Zoccali, Carmine, Jager, Kitty J

“…ABSTRACT In this article we introduce the concept of inverse probability of treatment weighting (IPTW) and describe how this method can be applied to adjust…”
Get full text

Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations by Fu, Edouard L, Levey, Andrew S, Coresh, Josef, Elinder, Carl-Gustaf, Rotmans, Joris I, Dekker, Friedo W, Paik, Julie M, Barany, Peter, Grams, Morgan E, Inker, Lesley A, Carrero, Juan-Jesus

“…Large discordances between eGFR on the basis of creatinine (eGFR cr ) or cystatin C (eGFR cys ) are common in clinical practice. However, which GFR estimating…”
Get full text

Merits and caveats of propensity scores to adjust for confounding by Fu, Edouard L, Groenwold, Rolf H H, Zoccali, Carmine, Jager, Kitty J, van Diepen, Merel, Dekker, Friedo W

“…Abstract Proper adjustment for confounding is essential when estimating the effects of treatments or risk factors on health outcomes in observational data. To…”
Get full text

Torque teno virus load as marker of rejection and infection in solid organ transplantation – A systematic review and meta‐analysis by Rijn, AL, Roos, R, Dekker, FW, Rotmans, JI, Feltkamp, MCW

“…Balancing immunosuppression to prevent rejection in solid organ transplant (SOT) recipients remains challenging. Torque teno virus (TTV), a commensal…”
Get full text

Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population by Fu, Edouard L, Coresh, Josef, Grams, Morgan E, Clase, Catherine M, Elinder, Carl-Gustaf, Paik, Julie, Ramspek, Chava L, Inker, Lesley A, Levey, Andrew S, Dekker, Friedo W, Carrero, Juan J

“…ABSTRACT Background While American nephrology societies recommend using the 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) estimated…”
Get full text

Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrumof kidney function by de, Jong Y, Fu, EL, van, Diepen M, Trevisan, M, Szummer, K, Dekker, FW, Carrero, JJ, Ocak, G

Get full text

Use of guideline‐recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence by Janse, Roemer J., Fu, Edouard L., Dahlström, Ulf, Benson, Lina, Lindholm, Bengt, Diepen, Merel, Dekker, Friedo W., Lund, Lars H., Carrero, Juan‐Jesus, Savarese, Gianluigi

“…Aim Half of heart failure (HF) patients have chronic kidney disease (CKD) complicating their pharmacological management. We evaluated physicians' and patients'…”
Get full text

Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function by de Jong, Ype, Fu, Edouard L, van Diepen, Merel, Trevisan, Marco, Szummer, Karolina, Dekker, Friedo W, Carrero, Juan J, Ocak, Gurbey

“…Abstract Aims  The increasing prevalence of ischaemic stroke (IS) can partly be explained by the likewise growing number of patients with chronic kidney…”
Get full text

Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study by Fu, Edouard L., Clase, Catherine M., Evans, Marie, Lindholm, Bengt, Rotmans, Joris I., Dekker, Friedo W., van Diepen, Merel, Carrero, Juan-Jesus

“…It is unknown whether initiating renin-angiotensin system (RAS) inhibitor therapy in patients with advanced chronic kidney disease (CKD) is superior to…”
Get full text

Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study by Fu, Edouard L, Evans, Marie, Carrero, Juan-Jesus, Putter, Hein, Clase, Catherine M, Caskey, Fergus J, Szymczak, Maciej, Torino, Claudia, Chesnaye, Nicholas C, Jager, Kitty J, Wanner, Christoph, Dekker, Friedo W, van Diepen, Merel

“…To identify the optimal estimated glomerular filtration rate (eGFR) at which to initiate dialysis in people with advanced chronic kidney disease. Nationwide…”
Get more information

Renal function decline in older men and women with advanced chronic kidney disease—results from the EQUAL study by Chesnaye, Nicholas C, Dekker, Friedo W, Evans, Marie, Caskey, Fergus J, Torino, Claudia, Postorino, Maurizio, Szymczak, Maciej, Ramspek, Chava L, Drechsler, Christiane, Wanner, Christoph, Jager, Kitty J

“…Abstract Introduction Understanding the mechanisms underlying the differences in renal decline between men and women may improve sex-specific clinical…”
Get full text

Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice by Fu, Edouard L., Clase, Catherine M., Janse, Roemer J., Lindholm, Bengt, Dekker, Friedo W., Jardine, Meg J., Carrero, Juan-Jesus

“…To investigate the comparative effectiveness of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1-RA) on…”
Get full text

Clinical impact of the Kidney Failure Risk Equation for vascular access planning by Lundström, Ulrika Hahn, Ramspek, Chava L, Dekker, Friedo W, van Diepen, Merel, Carrero, Juan Jesus, Hedin, Ulf, Evans, Marie

“…Risk-based thresholds for arteriovenous (AV) access creation has been proposed to aid vascular access planning. We aimed to assess the clinical impact of…”
Get full text

Association between use of beta-blockers and mortality/morbidity in patients with heart failure with reduced, midrange or preserved ejection fraction and advanced chronic kidney disease by Fu, E, Uijl, A, Dekker, F.W, Lund, L.H, Savarese, G, Carrero, J.J

“…Abstract Background Beta-blockers reduce mortality and morbidity in patients with heart failure (HF) with reduced ejection fraction (HFrEF). However, patients…”
Get full text

International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study by Hayward, Samantha, Hole, Barnaby, Denholm, Rachel, Duncan, Polly, Morris, James E, Fraser, Simon D S, Payne, Rupert A, Roderick, Paul, Chesnaye, Nicholas C, Wanner, Christoph, Drechsler, Christiane, Postorino, Maurizio, Porto, Gaetana, Szymczak, Maciej, Evans, Marie, Dekker, Friedo W, Jager, Kitty J, Caskey, Fergus J

“…Abstract Background People with chronic kidney disease (CKD) are at high risk of polypharmacy. However, no previous study has investigated international…”
Get full text

The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study by Dai, Lu, Massy, Ziad A, Stenvinkel, Peter, Chesnaye, Nicholas C, Larabi, Islam Amine, Alvarez, Jean Claude, Caskey, Fergus J, Torino, Claudia, Porto, Gaetana, Szymczak, Maciej, Krajewska, Magdalena, Drechsler, Christiane, Wanner, Christoph, Jager, Kitty J, Dekker, Friedo W, Evenepoel, Pieter, Evans, Marie

“…Trimethylamine N-oxide (TMAO), a metabolite from red meat and fish consumption, plays a role in promoting cardiovascular events. However, data regarding TMAO…”
Get full text

Symptom Burden before and after Dialysis Initiation in Older Patients by de Rooij, Esther N M, Meuleman, Yvette, de Fijter, Johan W, Jager, Kitty J, Chesnaye, Nicholas C, Evans, Marie, Caskey, Fergus J, Torino, Claudia, Porto, Gaetana, Szymczak, Maciej, Drechsler, Christiane, Wanner, Christoph, Dekker, Friedo W, Hoogeveen, Ellen K

“…For older patients with kidney failure, lowering symptom burden may be more important than prolonging life. Dialysis initiation may affect individual kidney…”
Get full text